Brucine

Brucine

SCHEMBL5592247

COc1cc2c(cc1OC)[C@@]13CCN4CC5=CCO[C@H]6CC(=O)N2[C@H]1[C@H]6[C@H]5C[C@H]43.O=C(O)C1=NN(c2ccc(Cl)cc2Cl)CC1

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TAS2R10 Q9NYW0 2/20 0.69
CHRM1 P11229 1/20 0.69
SMN1; SMN2 Q16637 1/20 0.69
GLRA1 P23415 14/20 0.56
GLRB P48167 14/20 0.56
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
CYP3A4 P08684 2/20 0.52
SCN1A P35498 1/20 0.52
TAS2R46 P59540 1/20 0.52
SCN2A Q99250 1/20 0.52
SCN3A Q9NY46 1/20 0.52
CYP1A2 P05177 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Brucine SCHEMBL1748435 0.89 TAS2R10 (0.67) TAS2R10CHRM1SMN1; SMN2GLRA1GLRB
Brucine SCHEMBL1748414 0.89 TAS2R10 (0.67) TAS2R10CHRM1SMN1; SMN2GLRA1GLRB
Brucine SCHEMBL7546669 0.83 TAS2R10 (0.94) TAS2R10CHRM1SMN1; SMN2GLRA1GLRB
Brucine SCHEMBL14029321 0.83 TAS2R10 (1.00) TAS2R10CHRM1SMN1; SMN2GLRA1GLRB
Brucine SCHEMBL10307298 0.83 TAS2R10 (1.00) TAS2R10CHRM1SMN1; SMN2GLRA1GLRB
Brucine SCHEMBL19476145 0.83 TAS2R10 (1.00) TAS2R10CHRM1SMN1; SMN2GLRA1GLRB
Brucine SCHEMBL1648976 0.83 TAS2R10 (1.00) TAS2R10CHRM1SMN1; SMN2GLRA1GLRB
Brucine SCHEMBL12293782 0.83 TAS2R10 (1.00) TAS2R10CHRM1SMN1; SMN2GLRA1GLRB
Brucine SCHEMBL7753865 0.83 TAS2R10 (0.84) TAS2R10CHRM1SMN1; SMN2GLRA1GLRB
Brucine SCHEMBL7253414 0.82 TAS2R10 (0.98) TAS2R10CHRM1SMN1; SMN2GLRA1GLRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007009706-A2 SUBSTITUTED PYRAZOLINE COMPOUNDS, HAVING PREDETERMINED STEREOCHEMISTRY, FOR REDUCING TRIGLYCERIDES IN BLOOD LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-01-25 WO disclosed